吐槽

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products_蜘蛛资讯网

was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by ap

nd its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in Augus

当前文章：http://j11ti4.zentaike.cn/nreb/if0.html

发布时间：00:57:22